Takotsubo syndrome in the context of the COVID-19 pandemic: An integrative review





Takotsubo Cardiomyopathy; COVID-19; Epidemiology; Pathophysiology; Psychological distress.


Introduction: Takotsubo syndrome (TTS) is characterized by a temporary left ventricular (LV) systolic dysfunction, usually in the context of acute physical or emotional stress. Thus, the stress mechanism generated by the pandemic and the COVID-19 infection has been related to this syndrome. Objective: To analyze, through a literature review, the relationship between COVID-19 and Takotsubo Syndrome, taking into account the pathophysiological mechanisms involved. Methods: This is a literature review with searches performed in July 2022, using the PubMed database. Results and Discussion: 29 articles were selected, after full evaluation, the main findings show an increase in the incidence of TTS in the general population and in patients with COVID-19. The pathophysiological mechanisms involved include the increase in catecholamines and cortisol, cytokine storm, microvascular dysfunction and the direct action of SARS-COV-2 on cardiomyocytes and endothelium, in addition to the psychological burden resulting from the pandemic. Conclusion: The incidence of stress-induced cardiomyopathy is expected to increase in the general population, driven by the psychosocial consequences of this period. Therefore, it is imperative that clinicians are familiar with the clinical presentation, possible complications, and management of TTS.


Abraham, J., Mudd, J. O., Kapur, N., Klein, K., Champion, H. C., & Wittstein, I. S. (2009). Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. Journal of the American College of Cardiology, 53(15), 1320-1325.

Angelini, P., Postalian, A., Hernandez-Vila, E., Uribe, C., & Costello, B. (2022). COVID-19 and the Heart: Could Transient Takotsubo Cardiomyopathy Be Related to the Pandemic by Incidence and Mechanisms?. Frontiers in Cardiovascular Medicine, 9.

Barbieri, L., Galli, F., Conconi, B., Gregorini, T., Lucreziotti, S., Mafrici, A., ... & Carugo, S. (2021). Takotsubo syndrome in COVID-19 era: Is psychological distress the key?. Journal of Psychosomatic Research, 140, 110297.

Boonen, E., Vervenne, H., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., ... & Van den Berghe, G. (2013). Reduced cortisol metabolism during critical illness. New England Journal of Medicine, 368(16), 1477-1488.

Chang, A., Wang, Y. G., Jayanna, M. B., Wu, X., Cadaret, L. M., & Liu, K. (2021). Mortality Correlates in Patients With Takotsubo Syndrome During the COVID-19 Pandemic. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 5(6), 1050-1055.

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., ... & Uriel, N. (2020). COVID-19 and cardiovascular disease. Circulation, 141(20), 1648-1655.

Eftekharzadeh, P., Patel, A., Sokolova, E., Rodas, A., & Ahmed, S. (2022). Takotsubo Cardiomyopathy: A COVID-19 Complication. Cureus, 14(3).

Ghadri, J. R., Sarcon, A., Diekmann, J., Bataiosu, D. R., Cammann, V. L., Jurisic, S., ... & Prasad, A. (2016). Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. European heart journal, 37(37), 2823-2829

Ghadri, J. R., Wittstein, I. S., Prasad, A., Sharkey, S., Dote, K., Akashi, Y. J., ... & Templin, C. (2018). International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. European Heart Journal, 39(22), 2047-2062.

Giustino, G., Croft, L. B., Oates, C. P., Rahman, K., Lerakis, S., Reddy, V. Y., & Goldman, M. (2020). Takotsubo cardiomyopathy in COVID-19. Journal of the American College of Cardiology, 76(5), 628-629.

Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., ... & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, 5(7), 811-818.

Haussner, W., DeRosa, A. P., Haussner, D., Tran, J., Torres-Lavoro, J., Kamler, J., & Shah, K. (2022). COVID-19 associated myocarditis: A systematic review. The American Journal of Emergency Medicine, 51, 150-155.

Jabri, A., Kalra, A., Kumar, A., Alameh, A., Adroja, S., Bashir, H., ... & Reed, G. W. (2020). Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA network open, 3(7), e2014780-e2014780.

Medina de Chazal, H., Del Buono, M. G., Keyser-Marcus, L., Ma, L., Moeller, F. G., Berrocal, D., & Abbate, A. (2018). Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. Journal of the American College of Cardiology, 72(16), 1955-1971.

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet, 395(10229), 1033-1034.

Meyer, P., Degrauwe, S., Van Delden, C., Ghadri, J. R., & Templin, C. (2020). Typical takotsubo syndrome triggered by SARS-CoV-2 infection. European Heart Journal, 41(19), 1860-1860.

Moady, G., & Atar, S. (2021). Takotsubo Syndrome during the COVID-19 Pandemic: State-of-the-Art Review. CJC open, 3(10), 1249-1256.

Montone, R. A., Iannaccone, G., Meucci, M. C., Gurgoglione, F., & Niccoli, G. (2020). Myocardial and microvascular injury due to coronavirus disease 2019. European Cardiology Review, 15.

Okura, H. (2021). Update of takotsubo syndrome in the era of COVID-19. Journal of cardiology, 77(4), 361-369.

Pfefferbaum, B., & North, C. S. (2020). Mental health and the Covid-19 pandemic. New England Journal of Medicine, 383(6), 510-512.

Rivers, J., & Ihle, J. F. (2020). COVID‐19 social isolation‐induced takotsubo cardiomyopathy. The Medical Journal of Australia, 213(7), 336-336.

Shah, R. M., Shah, M., Shah, S., Li, A., & Jauhar, S. (2021). Takotsubo syndrome and COVID-19: associations and implications. Current Problems in Cardiology, 46(3), 100763.

Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., ... & Huang, C. (2020). Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 5(7), 802-810.

Singh, S., Desai, R., Gandhi, Z., Fong, H. K., Doreswamy, S., Desai, V., ... & Kumar, G. (2020). Takotsubo syndrome in patients with COVID-19: a systematic review of published cases. SN Comprehensive Clinical Medicine, 2(11), 2102-2108.

Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106.

Techasatian, W., Nishimura, Y., Nagamine, T., Ha, G., Huang, R., Shah, P., ... & Kanitsoraphan, C. (2022). Characteristics of Takotsubo cardiomyopathy in patients with COVID-19: Systematic scoping review. American heart journal plus: cardiology research and practice, 100092.

Templin, C., Ghadri, J. R., Diekmann, J., Napp, L. C., Bataiosu, D. R., Jaguszewski, M., ... & Lüscher, T. F. (2015). Clinical features and outcomes of takotsubo (stress) cardiomyopathy. New England Journal of Medicine, 373(10), 929-938.

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., ... & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395(10234), 1417-1418.

Weekly epidemiological update on COVID-19 - 21 September 2022. (n.d.). Www.who.int. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2022

Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., ... & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269.



How to Cite

SANTOS, E. S. dos .; BURGOS, Úrsula M. M. C.; NOBRE, A. T. dos A. .; CRUZ, A. O. da; SANTANA, G. A. O. .; CANUTO, L. L.; MELO, M. F. R. M. .; MELO, M. N. de B. . Takotsubo syndrome in the context of the COVID-19 pandemic: An integrative review. Research, Society and Development, [S. l.], v. 11, n. 14, p. e587111436810, 2022. DOI: 10.33448/rsd-v11i14.36810. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/36810. Acesso em: 8 dec. 2022.



Health Sciences